Chosen Diagnostics

New Orleans, United States Founded: 2011 • Age: 15 yrs
Developing a novel MDx kit to diagnose a severe bowel disorder in premature infants
Request Access

About Chosen Diagnostics

Chosen Diagnostics is a company based in New Orleans (United States) founded in 2011.. Chosen Diagnostics operates in a competitive market with competitors including Inscripta, GenScript, OncoDNA, Sino Biological and BioLife Solutions, among others.

  • Headquarter New Orleans, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Chosen Diagnostics Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $224.76 K (USD), Grant

    Jun 15, 2020

  • Investors
    HHS

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Chosen Diagnostics

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $224,758
  • First Round

    (17 Nov 2018)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2020 Amount Grant - Chosen Diagnostics Valuation

investors

May, 2020 Amount Grant - Chosen Diagnostics Valuation

investors

HHS
Sep, 2019 Amount Grant - Chosen Diagnostics Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Chosen Diagnostics

Chosen Diagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, America’s Seed Fund and New Orleans BioInnovation Center. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund backed by the US Government
Founded Year Domain Location
A center dedicated to supporting biotech innovators in Louisiana.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Chosen Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Chosen Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chosen Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Chosen Diagnostics

Chosen Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, GenScript, OncoDNA, Sino Biological and BioLife Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Genomic and theranostic services for oncology precision medicine are delivered.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
domain founded_year HQ Location
Develops tools and products for research and clinical application
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chosen Diagnostics

Frequently Asked Questions about Chosen Diagnostics

When was Chosen Diagnostics founded?

Chosen Diagnostics was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is Chosen Diagnostics located?

Chosen Diagnostics is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.

What does Chosen Diagnostics do?

Chosen Diagnostics was founded in 2011 in New Orleans, United States, within the molecular diagnostics sector. Neonatal DDx, a diagnostic kit for necrotizing enterocolitis in premature infants, has been developed by the company. Human trials involving 49 patients have been completed, achieving 93 percent accuracy in disease identification. Operations focus on advancing diagnostic tools for neonatal bowel disorders.

Who are the top competitors of Chosen Diagnostics?

Chosen Diagnostics's top competitors include Sino Biological, OncoDNA and BioLife Solutions.

Who are Chosen Diagnostics's investors?

Chosen Diagnostics has 3 investors. Key investors include HHS, America’s Seed Fund, and New Orleans BioInnovation Center.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available